Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new chromogenic amylase method compared with two established methods.

J Fenton, R Foery, L Piatt

    Clinical Chemistry
    |April 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A survey of mental disorder in the long-term, rough sleeping, homeless population of inner Dublin.

    Irish journal of psychological medicine·2019
    Same author

    A survey of mental disorder in the long-term, rough sleeping, homeless population of inner Dublin - Corrigendum.

    Irish journal of psychological medicine·2019
    Same author

    Knockdown of Slingshot 2 (SSH2) serine phosphatase induces Caspase3 activation in human carcinoma cell lines with the loss of the Birt-Hogg-Dubé tumour suppressor gene (FLCN).

    Oncogene·2013
    Same author

    Iatrogenic tracheal tear.

    The West Indian medical journal·2011
    Same author

    Prophylactic Anti-typhoid Serum.

    British medical journal·2010
    Same author

    Expression of cell cycle associated proteins influences radiocurability of T2N0 squamous cell carcinoma of the larynx.

    Oral oncology·2008
    Same journal

    From Pooled Cohorts to PREVENT: A Perspective for Clinical Laboratorians.

    Clinical chemistry·2026
    Same journal

    Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

    Clinical chemistry·2026
    Same journal

    Comparison of Information-Dependent Acquisition and Sequential Window Acquisition of All Theoretical Mass Spectra for Untargeted Drug Testing on a Linear Ion Trap-Pulsing Quadrupole-Time of Flight Mass Spectrometer.

    Clinical chemistry·2026
    Same journal

    Patterns of One-Year Change in HbA1c and Continuous Glucose Monitoring (CGM) Metrics in Older Adults with Type 2 Diabetes.

    Clinical chemistry·2026
    Same journal

    TSH Pediatric Reference Intervals: Lack of CALIPER Applicability to US-Based Populations.

    Clinical chemistry·2026
    Same journal

    Rapid Detection of Hemoglobinopathy Variants Using One-Step Library Preparation and Nanopore Sequencing.

    Clinical chemistry·2026
    See all related articles

    A new amylase reagent, Pantrak, demonstrates excellent precision and a wide dynamic range. This chromogenic substrate method is reliable for clinical diagnostics, though certain anticoagulants interfere.

    Area of Science:

    • Clinical Chemistry
    • Biochemical Assays
    • Enzyme Kinetics

    Background:

    • Amylase is a key enzyme in carbohydrate metabolism.
    • Accurate amylase measurement is crucial for diagnosing pancreatic disorders.
    • Existing diagnostic methods require evaluation for improved clinical utility.

    Purpose of the Study:

    • To evaluate the analytical performance of a new chromogenic amylase reagent, Pantrak.
    • To assess its precision, dynamic range, and potential interferences compared to established methods.

    Main Methods:

    • Pantrak utilizes p-nitrophenyl-alpha-maltaosides as chromogenic substrates.
    • Amylase activity is indirectly measured by quantifying p-nitrophenol released via alpha-glucosidase.
    • A series of 100 clinical specimens were analyzed using Pantrak and two reference methods.

    Related Experiment Videos

    Main Results:

    • Pantrak showed excellent correlation with established amylase testing methodologies.
    • The reagent exhibited good precision, with coefficients of variation (CVs) ranging from 3.0% to 4.5%.
    • Pantrak demonstrated a broad dynamic range up to 800 U/L and was unaffected by common interferents like triglycerides, hemoglobin, and bilirubin.

    Conclusions:

    • The Pantrak amylase reagent possesses desirable analytical characteristics for clinical use.
    • Its ease of use and reliable performance make it a suitable alternative for amylase determination.
    • Caution is advised regarding the use of anticoagulants that chelate divalent cations.